Blueberries Medical Corp.
BBM
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.76% | 46.50% | 34.64% | 41.26% | -5,773.47% |
| Total Depreciation and Amortization | -24.51% | -73.76% | 2,137.50% | 92.31% | 483.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.07% | -1,111.11% | -49.28% | -74.30% | 140.78% |
| Change in Net Operating Assets | 66.08% | -159.46% | 133.96% | 89.61% | -120.89% |
| Cash from Operations | -7.11% | -17.03% | 70.25% | 53.41% | 6.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 98.47% | -100.00% | -94.88% | -- | -2,569.70% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -102.61% | -100.00% | -94.46% | -- | 1,666.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.99% | 99.24% | 90.00% | 97.28% | -7,694.97% |
| Issuance of Common Stock | -- | -- | -- | -- | 35.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 71.75% |
| Cash from Financing | -100.02% | 98.98% | 89.89% | 97.06% | -59.02% |
| Foreign Exchange rate Adjustments | 116.24% | -97.57% | -- | 190.58% | -367.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.38% | -504.51% | 38.48% | 62.30% | -82.73% |